Stock GBSX MARIZYME, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Marizyme, Inc.

Equities

GBSX

US5703721028

Market Closed - OTC Markets
Other stock markets
 14:20:59 2024-06-20 EDT 		5-day change 1st Jan Change
0.0541 USD -41.83% Intraday chart for Marizyme, Inc. 0.00% -45.95%
05-28 Marizyme, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-13 Marizyme, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Marizyme, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Marizyme, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Marizyme : Secures FDA 510(k) Clearance for Controlled Room Temperature storage DuraGraft® - Form 8-K
PU
Marizyme, Inc. Secures FDA 510(k) Clearance for Controlled Room Temperature Storage DuraGraft
AQ
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
GL
Marizyme, Inc. Announces Resignation of Julie Kampf from the Board of Directors
CI
Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Marizyme CEO Delivers Business Update
EQ
Marizyme CEO Delivers Business Update
GL
OTC Active Stocks Watchlist (EPAZ, MRZM, GCEI, TMGI)
AQ
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™
GL
Marizyme, Inc. Announces FDA Clearance for Product, Duragraft
CI
Marizyme, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
MARIZYME, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
Marizyme, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Marizyme, Inc. announced a financing transaction
CI
MARIZYME INC : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
GL
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
AQ
Marizyme, Inc. Announces IP Developments for DuraGraft and its Pipeline of Products
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GBSX Stock
  4. News Marizyme, Inc.